Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 206

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Perfluorinated compounds: Emerging POPs with potential immunotoxicity

Open access
Corsini, Emanuela, Luebke, Robert W., Germolec, Dori R., DeWitt, Jamie C. · 2014 · Toxicology Letters

Abstract

Perfluorinated compounds (PFCs) have been recognized as an important class of environmental contaminants commonly detected in blood samples of both wildlife and humans. These compounds have been in use for more than 60 years as surface treatment chemicals, polymerization aids, and surfactants. They possess a strong carbon-fluorine bond, which leads to their environmental persistence. There is evidence from both epidemiology and laboratory studies that PFCs may be immunotoxic, affecting both cell-mediated and humoral immunity. Reported effects of PFCs include decreased spleen and thymus weights and cellularity, reduced antibody production, reduced survival after influenza infection, and altered cytokine production. Immunosuppression is a critical effect associated with exposure to PFCs, as it has been reported to reduce antibody responses to vaccination in children. Mounting evidence suggests that immunotoxicity in experimental animals can occur at serum concentrations below, within, or just above the reported range for highly exposed humans and wildlife. Considering bioaccumulation and exposure to multiple PFCs, the risk of immunotoxicity for humans and wildlife cannot be discounted. This review will discuss current and recently published work exploring the immunomodulatory effects of PFCs in experimental animals and humans.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.toxlet.2014.01.038

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Research works printed but not linked: 66

  1. Alexander, 2007, Bladder cancer in perfluorooctanesulfonyl fluoride manufacturing workers, Ann. Epidemiol., 17, 471, 10.1016/j.annepidem.2007.01.036 · DOI
  2. Biegel, 2001, Mechanisms of extrahepatic tumor induction by peroxisome proliferators in male CD rats, Toxicol. Sci., 60, 44, 10.1093/toxsci/60.1.44 · DOI · Paper page
  3. Brieger, 2011, Impact of perfluorooctanesulfonate and perfluorooctanoic acid on human peripheral leukocytes, Toxicol. In Vitro, 25, 960, 10.1016/j.tiv.2011.03.005 · DOI
  4. Butenhoff, 2004, Characterization of risk for general population exposure to perfluorooctanoate, Regul. Toxicol. Pharmacol., 39, 363, 10.1016/j.yrtph.2004.03.003 · DOI
  5. Cain, 2010, The relationship between serum uric acid and chronic kidney disease among Appalachian adults, Nephrol. Dial. Transplant., 25, 3593, 10.1093/ndt/gfq262 · DOI
  6. Calafat, 2006, Human exposure assessment to environmental chemicals using biomonitoring, Int. J. Androl., 29, 166, 10.1111/j.1365-2605.2005.00570.x · DOI
  7. Calafat, 2007, Serum concentrations of 11 polyfluoroalkyl compounds in the US population: data from the National Health and Nutrition examination survey, Environ. Sci. Technol., 41, 2237, 10.1021/es062686m · DOI · Paper page
  8. Cheung, 2004, Diminished hepatocellular proliferation in mice humanized for the nuclear receptor peroxisome proliferator-activated receptor-α, Cancer Res., 64, 3849, 10.1158/0008-5472.CAN-04-0322 · DOI · Paper page
  9. Corsini, 2011, In vitro evaluation of the immunotoxic potential of perfluorinated compounds (PFCs), Toxicol. Appl. Pharmacol., 250, 108, 10.1016/j.taap.2010.11.004 · DOI
  10. Corsini, 2012, In vitro characterization of the immunotoxic potential of several perfluorinated compounds (PFCs), Toxicol. Appl. Pharmacol., 258, 248, 10.1016/j.taap.2011.11.004 · DOI · Paper page
  11. Dewitt, 2008, Perfluorooctanoic acid-induced immunomodulation in adult C57BL/6J or C57BL/6N female mice, Environ. Health Perspect., 116, 644, 10.1289/ehp.10896 · DOI · Paper page
  12. DeWitt, 2009, Immunotoxicity of perfluorooctanoic acid and perfluorooctane sulfonate and the role of peroxisome proliferator-activated receptor alpha, Crit. Rev. Toxicol., 39, 76, 10.1080/10408440802209804 · DOI · Paper page
  13. DeWitt, 2009, Suppression of humoral immunity by perfluorooctanoic acid is independent of elevation serum corticosterone concentration in mice, Toxicol. Sci, 109, 106, 10.1093/toxsci/kfp040 · DOI
  14. DeWitt, 2009, Immunotoxicity of perfluorooctanoic acid and perfluorooctane sulfonate and the role of peroxisome proliferator-activated receptor alpha, Crit. Rev. Toxicol., 39, 76, 10.1080/10408440802209804 · DOI · Paper page
  15. DeWitt, 2012, Immunotoxicity of perfluorinated compounds: recent developments, Toxicol. Pathol., 40, 300, 10.1177/0192623311428473 · DOI · Paper page
  16. Dietert, 2008, Developmental immunotoxicology (DIT): windows of vulnerability, immune dysfunction and safety assessment, J. Immunotoxicol., 5, 401, 10.1080/15476910802483324 · DOI
  17. Domingo, 2012, Health risks of dietary exposure to perfluorinated compounds, Environ. Int., 40, 187, 10.1016/j.envint.2011.08.001 · DOI · Paper page
  18. Dong, 2011, Sub-chronic effect of perfluorooctanesulfonate (PFOS) on the balance of type 1 and type 2 cytokine in adult C57BL6 mice, Arch. Toxicol., 85, 1235, 10.1007/s00204-011-0661-x · DOI
  19. EFSA, 2012, Perfluorinated substances in food: occurrence and dietary exposure, EFSA J., 10, 2743, 10.2903/j.efsa.2012.2743 · DOI
  20. Emmett, 2006, Community exposure to perfluorooctanoate: relationships between serum levels and certain health parameters, J. Occup. Environ. Med., 48, 771, 10.1097/01.jom.0000233380.13087.37 · DOI · Paper page
  21. Eriksen, 2013, Association between plasma PFOA and PFOS levels and total cholesterol in a middle-aged Danish population, PLoS One, 8, e56969, 10.1371/journal.pone.0056969 · DOI · Paper page
  22. Fair, 2011, Effects of environmentally-relevant levels of perfluorooctane sulfonate on clinical parameters and immunological functions in B6C3F1 mice, J. Immunotoxicol., 8, 17, 10.3109/1547691X.2010.527868 · DOI
  23. Fang, 2009, Alterations of cytokines and MAPK signaling pathways are related to the immunotoxic effect of perfluorononanoic acid, Toxicol. Sci., 108, 367, 10.1093/toxsci/kfp019 · DOI
  24. Fei, 2012, Prenatal exposure to PFOA and PFOS and risk of hospitalization for infectious diseases in early childhood, Environ. Res., 110, 773, 10.1016/j.envres.2010.08.004 · DOI
  25. Germolec, 2004, Sensitivity and predictivity in immunotoxicity testing: immune endpoints and disease resistance, Toxicol. Lett., 149, 109, 10.1016/j.toxlet.2003.12.025 · doi:10.1016/j.toxlet.2003.12.025
  26. Gilliland, 1993, Mortality among employees of a perfluorooctanoic acid production plant, J. Occup. Med., 35, 950, 10.1097/00043764-199309000-00020 · DOI · Paper page
  27. Gonzalez, 1998, Mechanism of action of thenon-genotoxic peroxisome proliferators: role of the peroxisome proliferator activator receptor alpha, J. Natl. Cancer Inst., 90, 1702, 10.1093/jnci/90.22.1702 · DOI · Paper page
  28. Grandjean, 2012, Serum vaccine antibody concentrations in children exposed to perfluorinated compounds, JAMA, 307, 391, 10.1001/jama.2011.2034 · DOI · Paper page
  29. Guruge, 2009, Effect of perfluorooctane sulfonate (PFOS) on influenza A virus-induced mortality in female B6C3F1 mice, J. Toxicol. Sci., 34, 687, 10.2131/jts.34.687 · DOI
  30. Holsapple, 2004, Symposium summary: children's health risk–what's so special about the developing immune system?, Toxicol. Appl. Pharmacol., 199, 61, 10.1016/j.taap.2004.03.003 · DOI
  31. Kato, 2009, Polyfluoroalkyl compounds in pooled sera from children participating in the National Health and Nutrition Examination Survey 2001–2002, Environ. Sci. Technol., 43, 2641, 10.1021/es803156p · DOI
  32. Lefebvre, 2008, Immunomodulatory effects of dietary potassium perfluorooctane sulfonate (PFOS) exposure in adult Sprague-Dawley rats, J. Toxicol. Environ. Health A, 71, 1516, 10.1080/15287390802391943 · DOI
  33. Leonard, 2008, Retrospective cohort mortality study of workers in a polymer production plant including a reference population of regional workers, Ann. Epidemiol., 18, 15, 10.1016/j.annepidem.2007.06.011 · DOI · Paper page
  34. Liu, 1996, The direct effect of hepatic peroxisome proliferators on rat Leydig cell function in vitro, Fundam. Appl. Toxicol., 30, 102, 10.1006/faat.1996.0047 · DOI
  35. Liu, 1996, Effect of the peroxisome proliferator, ammonium perfluorooctanoate (C8), on hepatic aromatase activity in adult male Crl:CDBR (CD) rats, Fundam. Appl. Toxicol., 30, 220, 10.1006/faat.1996.0059 · DOI
  36. Loveless, 2008, Evaluation of the immune system in rats and mice administered linear ammonium perfluorooctanoate (APFO), Toxicol. Sci., 105, 86, 10.1093/toxsci/kfn113 · DOI
  37. Luster, 1992, Risk assessment in immunotoxicology: I. Sensitivity and predictability of immune tests, Fundam. Appl. Toxicol., 18, 200, 10.1016/0272-0590(92)90047-L · DOI · Paper page
  38. Luster, 2005, Biomarkers to assess potential developmental immunotoxicity in children, Toxicol. Appl. Pharmacol., 206, 229, 10.1016/j.taap.2005.02.010 · DOI
  39. Luster, 1993, Risk assessment in immunotoxicology. II. Relationships between immune and host resistance tests, Fundam. Appl. Toxicol., 21, 71, 10.1006/faat.1993.1074 · DOI · Paper page
  40. Okada, 2012, Prenatal exposure to perfluorinated chemicals and relationship with allergies and infectious diseases in infants, Environ. Res., 112, 118, 10.1016/j.envres.2011.10.003 · DOI
  41. Olsen, 1999, Serum perfluorooctane sulfonate and hepatic and lipid clinical chemistry tests in fluorochemical production employees, J. Occup. Environ. Med., 41, 799, 10.1097/00043764-199909000-00012 · DOI · Paper page
  42. Palmer, 1998, Peroxisome proliferator activated receptor-alpha expression in human liver, Mol. Pharmacol., 53, 14, 10.1124/mol.53.1.14 · DOI · Paper page
  43. Pastoor, 1987, Biochemical and morphological studies of ammonium perfluorooctanoate-induced hepatomegaly and peroxisome proliferation, Exp. Mol. Pathol., 47, 98, 10.1016/0014-4800(87)90011-6 · DOI
  44. Peden-Adams, 2009, Health effects of perfluorinated compounds—what are the wildlife telling us?, Reprod. Toxicol., 27, 414, 10.1016/j.reprotox.2008.11.016 · DOI
  45. Peden-Adams, 2007, Suppression of humoral immunity following exposure to the perfluorinated insecticide sulfluramid, J. Toxicol. Environ. Health A, 70, 1130, 10.1080/15287390701252733 · DOI
  46. Peden-Adams, 2008, Suppression of humoral immunity in mice following exposure to perfluorooctane sulfonate, Toxicol. Sci., 104, 144, 10.1093/toxsci/kfn059 · DOI · Paper page
  47. Peden-Adams, 2010, Effects of perfluorooctanesulfonic acid (PFOS) on NF-kB, AP-1, and PPAR-alpha, Toxicologist, 114, 330
  48. Peraza, 2006, The toxicology of ligands for peroxisome proliferator-activated receptors (PPAR), Toxicol. Sci., 90, 269, 10.1093/toxsci/kfj062 · DOI · Paper page
  49. Qazi, 2010, Toxicology, 267, 132, 10.1016/j.tox.2009.10.035 · DOI
  50. Rayne, 2009, Perfluoroalkyl sulfonic and carboxylic acids: a critical review of physicochemical properties, levels and patterns in waters and wastewaters, and treatment methods, J. Environ. Sci. Health A Tox. Hazard Subst. Environ. Eng., 44, 1145, 10.1080/10934520903139811 · DOI · Paper page
  51. Saccani, 2002, p38-Dependent marking of inflammatory genes for increased NF-kappa B recruitment, Nat. Immunol., 3, 69, 10.1038/ni748 · DOI · Paper page
  52. Schmitz, 2001, I kappa B-independent control of NF-kappa B activity by modulatory phosphorylations, Trends Biochem. Sci., 26, 186, 10.1016/S0968-0004(00)01753-9 · DOI · Paper page
  53. Steenland, 2010, Epidemiologic evidence on the health effects of perfluorooctanoic acid (PFOA), Environ. Health Perspect., 118, 1100, 10.1289/ehp.0901827 · DOI · Paper page
  54. Suja, 2009, Contamination, bioaccumulation and toxic effects of perfluorinated chemicals (PFCs) in the water environment: a review paper, Water Sci. Technol., 60, 1533, 10.2166/wst.2009.504 · DOI · Paper page
  55. Ubel, 1980, Health status of plant workers exposed to fluorochemicals–a preliminary report, Am. Ind. Hyg. Assoc. J., 41, 584, 10.1080/15298668091425310 · DOI
  56. Vermeulen, 2002, Regulation of the transcriptional activity of the nuclear factor-kappaB p65 subunit, Biochem. Pharmacol., 64, 963, 10.1016/S0006-2952(02)01161-9 · DOI · Paper page
  57. Vermeulen, 2003, Transcriptional activation of the NF-kappaB p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1), EMBO J., 22, 1313, 10.1093/emboj/cdg139 · DOI · Paper page
  58. van Loveren, 1999, Report of the Bilthoven symposium: advancement of epidemiological studies in assessing the human health effects of immunotoxic agents in the environment and the workplace, Biomarkers, 4, 135, 10.1080/135475099230949 · DOI
  59. Vestergren, 2009, Tracking the pathways of human exposure to perfluorocarboxylates, Environ. Sci. Technol., 43, 5565, 10.1021/es900228k · DOI · Paper page
  60. Yang, 2000, Effects of peroxisome proliferators on the thymus and spleen of mice, Clin. Exp. Immunol., 122, 219, 10.1046/j.1365-2249.2000.01367.x · DOI
  61. Yang, 2001, Further evidence for the involvement of inhibition of cell proliferation and development in thymic and splenic atrophy induced by the peroxisome proliferator perfluoroctanoic acid in mice, Biochem. Pharmacol., 62, 1133, 10.1016/S0006-2952(01)00752-3 · DOI
  62. Yang, 2002, Potent suppression of the adaptive immune response in mice upon dietary exposure to the potent peroxisome proliferators perfluorooctanoic acid, Int. Immunopharmacol., 2, 389, 10.1016/S1567-5769(01)00164-3 · DOI · Paper page
  63. Wang, 2011, The effect of prenatal perfluorinated chemicals exposures on pediatric atopy, Environ. Res., 111, 785, 10.1016/j.envres.2011.04.006 · DOI
  64. Weihe, 2008, Serum concentrations of polyfluoroalkyl compounds in Faroese whale meat consumers, Environ. Sci. Technol., 42, 6219, 10.1021/es800695m · DOI
  65. Zareitalabad, 2013, Perfluorooctanoic acid (PFOA) and perfluoroocanesulfonic acid (PFOS) in surface waters, sediments, soils and wastewater–a reveiw on concentrations and distributions coefficients, Chemosphere, 91, 725, 10.1016/j.chemosphere.2013.02.024 · DOI · Paper page
  66. Zheng, 2011, Type 1 and Type 2 cytokines imbalance in adult male C57BL/6 mice following a 7-day oral exposure to perfluorooctanesulfonate (PFOS), J. Immunotoxicol., 8, 30, 10.3109/1547691X.2010.537287 · DOI

Cited by

See all 206

Metadata

Authors
Corsini, E., Luebke, R. W., Germolec, D. R., & DeWitt, J. C.
Venue
Toxicology Letters
Publisher
Elsevier BV
Published
2014-10
Volume
230
Issue
2
Pages
263-270
ISSN
0378-4274 (ISSN-L)
OpenAlex
W2001939379
Cited by
206
References
12
FWCI
9.97
Type
journal article
Language
en
Open access
green
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Perfluorinated compounds: Emerging POPs with potential immunotoxicity. https://app.cochat.ai/papers/10.1016/j.toxlet.2014.01.038
The paper
Corsini, E., Luebke, R. W., Germolec, D. R., & DeWitt, J. C. (2014). Perfluorinated compounds: Emerging POPs with potential immunotoxicity. Toxicology Letters. https://doi.org/10.1016/j.toxlet.2014.01.038

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.